CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 165 enrolled
Drug / intervention
SandRAprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02424877
NCT02424877N/ACompleted
CompareCT.gov

Cell Phone Based Automated Monitoring of Patients With Early Rheumatoid Arthritis

Medcare Oy·interventional·Posted Apr 23, 2015·Updated Oct 5, 2017

In Brief

A clinical study evaluating SandRA for Rheumatoid Arthritis. Completed, enrolled 165 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine whether automated remote monitoring of patients with early rheumatoid arthritis by the SandRA software and short message service of cell phones increases patient compliance and helps to identify patients needing re-assessment of medication before scheduled visits. This might result in better clinical outcome and cost-effectiveness.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesFinland
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedApr 23, 2015
Enrollment StartAug 1, 2013
Primary CompletionJan 30, 2016
Study CompletionJan 2, 2017
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 11.2 years ago

Interventions

SandRAprocedure

SandRA software sends SMS messages to a patient asking questions about the usage and adverse effects of prescribed drugs and about the severity of rheumatoid arthritis. The answer messages are interpreted automatically.